Chlorotrimethylsilane → HCID 44467674, compound
Reaction equation
Cl[C:2]1[N:3]=[C:4]([NH:24][CH:25]2[CH2:27][CH2:26]2)[C:5]2[C:10]([C:11](=[O:13])[CH3:12])=[CH:9][N:8](S(C3C=CC(C)=CC=3)(=O)=O)[C:6]=2[N:7]=1.[NH2:28][C:29]1[CH:37]=[C:36]2[C:32]([CH:33]=[N:34][NH:35]2)=[CH:31][CH:30]=1.C[Si](Cl)(C)C>C(O)CCC>[NH:35]1[C:36]2[C:32](=[CH:31][CH:30]=[C:29]([NH:28][C:2]3[N:3]=[C:4]([NH:24][CH:25]4[CH2:26][CH2:27]4)[C:5]4[C:10]([C:11](=[O:13])[CH3:12])=[CH:9][NH:8][C:6]=4[N:7]=3)[CH:37]=2)[CH:33]=[N:34]1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 116 °C
Procedure
A mixture of 1-(2-chloro-4-(cyclopropylamino)-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)ethanone (85 mg, 0.21 mmol), 6-aminoindazole (56 mg, 0.42 mmol) and TMSCl (0.070 mL, 0.55 mmol) in nBuOH (3 mL) was stirred at 116° C. for 18 h. It was then concentrated in vacuo. The residue was purified by HPLC to give the titled compound (30 mg). MS 348.1 (M+H); UV 248.7, 305.7 nm.
Workup
- concentrationIt was then concentrated in vacuo
- customThe residue was purified by HPLC
Sources & evidence
- ORD record
- ord-daa557d433a74069a9b3b44d0333bbfd
- Source dataset
- uspto-grants-2012_09
- Patent number
- US08258144B2
Reaction notes
Loading…